Naveen Garg - Concepedia

Author

Naveen Garg

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Garg, Naveen, Marena Garduno, N. Garg, NAVEEN GARG, Naveen GARG, Naveen Garg

266

Publications

4.4K

Citations

H-Index

143

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center CSIR National Physical Laboratory of India Baylor College of Medicine Council of Scientific and Industrial Research The University of Texas Health Science Center at Houston

About

Naveen Garg is an author at The University of Texas MD Anderson Cancer Center specializing in engineering, noise, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	15	22	555
2	Health Sciences	9	9	278
3	Education	3	3	104
4	Arts	1	1	14
5	Business	1	1	45

Naveen Garg

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Ibrutinib and Venetoclax for First-Line Treatment of CLL Nitin Jain, Michael J. Keating, Philip A. Thompson, New England Journal of Medicine	2019	491
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study Jan A. Burger, Michael J. Keating, William G. Wierda, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaOncologyImmunologyHematology	2014	330
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge Christine M. Parseghian, Jonathan M. Loree, Van K. Morris, Annals of Oncology	2018	228
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer Amanda Cooper, Rebecca Slack, David R. Fogelman, Annals of Surgical Oncology Surgical OncologyPancreatic CancerNeoadjuvant TherapyGastrointestinal OncologyMedicine	2014	155
Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison Abdallah Mohamed, Brian P. Hobbs, Katherine A. Hutcheson, Radiotherapy and Oncology Adaptive RadiotherapyHealth SciencesRadiation TherapyMedicineMandibular Osteoradionecrosis	2017	111
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia Nitin Jain, Michael J. Keating, Philip A. Thompson, JAMA Oncology	2021	108
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma Eugene J. Koay, Yeon‐Ju Lee, Vittorio Cristini, Clinical Cancer Research	2018	107
Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib Dominik Wodarz, Naveen Garg, Natalia L. Komarova, Blood	2014	101
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation Mani Akhtari, Sarah A. Milgrom, Chelsea C. Pinnix, Blood	2017	100
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib Jan A. Burger, Kelvin W. Li, Michael J. Keating, JCI Insight	2017	91

Page 1